BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives. 2022

Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Pharmaceutical Department, Changzhi Medical College, Changzhi 046000, China.

In order to find high-efficiency and low-toxic anti-tumor drugs, 29 pyrido[3,4-d]pyrimidine compounds were designed, synthesized and evaluated by MTT assay in vitro. The results presented that most of the compounds had good antitumor activities, among which compound 30 had the best anti-tumor activity on MGC803 cells (IC50 = 0.59 μM). Mechanistic studies exhibited that compound 30 inhibited migration of MGC803 and induced apoptosis. It was proved that compound 30 up-regulated expression of Bid and PARP, down-regulated expression of CycD1 by western blot experiments. This study indicated that compound 30 might be served as a lead agent for the treatment of human gastric cancers.

UI MeSH Term Description Entries
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051023 BH3 Interacting Domain Death Agonist Protein A member of the Bcl-2 protein family that reversibly binds MEMBRANES. It is a pro-apoptotic protein that is activated by caspase cleavage. Bid Protein,tBid Protein,Truncated Bid Protein

Related Publications

Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
August 2016, European journal of medicinal chemistry,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Design, synthesis and anti-osteosarcoma activity study of novel pyrido[2,3-d]pyrimidine derivatives by inhibiting DKK1-Wnt/β-catenin pathway.
December 2023, Bioorganic chemistry,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist.
March 2022, European journal of medicinal chemistry,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors.
July 2023, Bioorganic chemistry,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
August 2011, European journal of medicinal chemistry,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Synthesis and antimicrobial activity of new amino derivatives of pyrano[4'',3'':4',5']pyrido[3',2':4,5]thieno[3,2-d]pyrimidine.
January 2018, Anais da Academia Brasileira de Ciencias,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
October 2011, European journal of medicinal chemistry,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Synthesis of Novel Pyrido[1,2-a]pyrimidine-3-carboxamide Derivatives and Their Anticancer Activity.
January 2015, Chemical & pharmaceutical bulletin,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Studies on synthesis of novel pyrido[2,3-d]pyrimidine derivatives, evaluation of their antimicrobial activity and molecular docking.
May 2018, Bioorganic & medicinal chemistry letters,
Wen-Ge Guo, and Jun-Ru Zhao, and Min Li, and Ting Hu, and Zengyangzong Dan, and Qian Zhang, and Li-Ying Ma, and Sai-Yang Zhang, and Bing Zhao
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors.
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!